Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01784861
Brief Title: VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors

First Submitted : February 4, 2013
First Submitted that Met QC Criteria : February 5, 2013
First Posted : February 6, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : July 15, 2019
Last Update Posted : July 18, 2019